FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: California, a major hub for biotechnology and pharmaceutical research, stands to be significantly impacted by the FDA's decision, potentially influencing investment, research, and manufacturing within the state's life sciences sector.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.